When is stem-cell transplantation indicated in the treatment of Waldenström macroglobulinemia?

Updated: Feb 01, 2021
  • Author: Karen Seiter, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

High-dose chemotherapy with autologous peripheral blood cell transplantation is reserved for selected younger patients with primary refractory or relapsed disease. In a study of 6 patients who received autologous transplant, Desikan et al reported that long-term control can be achieved even in patients with refractory disease. [53] Reduced-intensity allogeneic stem cell transplantion may be an option in very select patients.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!